Day: October 25, 2018

Advocate General for Northern Ireland, Geoffrey Cox QC MP, will be called to the Bar of Northern Ireland on Friday 26 October.

The call ceremony will be presided over by the Lord Chief Justice. The Advocate General will host a reception at the Royal Courts of Justice after the ceremony for key figures from the legal world.

While in Northern Ireland the Advocate General will hold separate meetings with key legal figures including Attorney General for Northern Ireland, John Larkin QC, Lord Chief Justice of Northern Ireland, Sir Charles Declan Morgan QC PC, Chair of the Bar Council in Northern Ireland, Sarah Ramsey, Director of Public Prosecutions, Stephen Herron and his deputy Michael Agnew. These will be closed meetings to discuss legal issues in Northern Ireland.

Advocate General for Northern Ireland, Geoffrey Cox QC MP said:

It is a privilege to be called to the Bar of Northern Ireland. I am looking forward to the ceremony and to meeting members of judiciary and the legal professions.

The Call ceremony will take place on Friday 26 October at the Royal Courts of Justice.

The position of Advocate General for Northern Ireland is held by the Attorney General for England and Wales by virtue of that office.

Sunil Kumar Ralhan (37) appeared at Birmingham Crown Court on 5 October 2018 and in addition to the court-ordered disqualification for 7 years, the company director received a 9-month prison sentence.

The court heard that Sunil Ralhan was the sole director of Travelogue Ltd from November 2014, having bought the travel agency from its former director.

However, the company was placed in liquidation in May 2015 after it failed to recover payments from travel agents based abroad who had bought tickets through Travelogue. The travel agency was later dissolved in February 2017.

Independent insolvency practitioners were appointed to take charge of liquidating the company but Sunil Ralhan had failed to keep adequate accounting records, while also failing to share them with the insolvency practitioners and later, investigators from the Insolvency Service.

Failure to deliver information requested by the liquidator while winding up a company is evidence of misconduct and in Sunil Ralhan’s case, it would have helped explain a deficiency in the liquidation of close to £380,000 that was owed primarily to a single creditor of Travelogue.

Glenn Wicks, Chief Investigator for the Insolvency Service, said:

“As the director of the company, albeit on behalf of others, this man was responsible for keeping books and records. By not providing them he covered up what was almost certainly a fraud and that is why he received this imprisonment.”

At an earlier hearing, Sunil Ralhan accepted that he failed to keep accounting records that were sufficient to show and explain the transactions of the company.

Notes to editors

Sunil Ralhan is from Birmingham and was born in August 1981.

Travelogue Limited (company no. 07705471) was incorporated on 14 July 2011.

A disqualification order has the effect that without specific permission of a court, a person with a disqualification cannot:

• act as a director of a company
• take part, directly or indirectly, in the promotion, formation or management of a company or limited liability partnership
• be a receiver of a company’s property

Persons subject to a disqualification order are bound by a range of other restrictions

The Insolvency Service administers the insolvency regime, investigating all compulsory liquidations and individual insolvencies (bankruptcies) through the Official Receiver to establish why they became insolvent. It may also use powers under the Companies Act 1985 to conduct confidential fact-finding investigations into the activities of live limited companies in the UK. In addition, the agency deals with disqualification of directors in corporate failures, assesses and pays statutory entitlement to redundancy payments when an employer cannot or will not pay employees, provides banking and investment services for bankruptcy and liquidation estate funds and advises ministers and other government departments on insolvency law and practice.

Further information about the work of the Insolvency Service, and how to complain about financial misconduct, is available.

Contact Press Office

Media enquiries for this press release – 020 7674 6910 or 020 7596 6187

You can also follow the Insolvency Service on:

• Twitter
• LinkedIn
• YouTube

Today (Thursday, 25 October), the Prime Minister has confirmed the appointments of Lord Bew as Chair of the House of Lords Appointments Commission and Lord Evans of Weardale as the Chair of the Committee on Standards in Public Life.

The appointments follow open recruitment exercises, including pre-appointment scrutiny by the Public Administration and Constitutional Affairs Committee.

Lord Bew

Lord Bew is the current Chair of the Committee on Standards in Public Life, Professor of Irish Politics at Queen’s University Belfast and former historical adviser to the Bloody Sunday Inquiry. He was appointed as a crossbench peer in 2007 following his contributions to the Belfast Agreement.

The Minister for Implementation, Oliver Dowden MP, welcomed Lord Bew’s appointment:

Lord Bew has demonstrated his dedication to ensuring diversity in appointments in his post as Chair of the Committee on Standards in Public Life. I welcome his clear commitment to the principle that the membership of the House of Lords should better reflect the nation.

The Minister also took the opportunity to thank Lord Bew’s predecessor, Lord Kakkar:

Lord Kakkar’s steady handling of the Commission has been vital to the continued integrity of the appointments process. His advice and approach have been hugely valued.

The House of Lords Appointments Commission (HOLAC) has two main functions:

• to recommend individuals for appointment as non-party-political life peers
• to vet nominations for life peers, including those nominated by the UK political parties, to ensure the highest standards of propriety

The Commission’s Chair is appointed for a non-renewable, five-year term of office. More information about the Commission can be found on the House of Lords Appointments Commission website.

Lord Evans of Weardale

Lord Evans of Weardale is the new Chair of the Committee on Standards in Public Life, to fill the position left vacant by Lord Bew. Lord Evans spent 33 years in the UK Security Service, six as Director General, when he was a senior advisor to the UK government on national security policy and a member of the Prime Minister’s National Security Council. Lord Evans was appointed as a crossbench peer for his contribution to public service in 2014.

Minister Dowden also welcomed Lord Evans’ appointment:

The Committee on Standards in Public Life contributes to the maintenance of the diversity, integrity, and vibrancy of representative democracy in the UK. Lord Evans has demonstrated all the skills necessary for this sensitive post, including the highest integrity and an understanding of the issues of standards in public life.

The Committee on Standards in Public Life is an advisory non-departmental public body. Its purpose is to examine areas of concern about the standards of conduct of public office holders, advise the Prime Minister accordingly, and to promote the highest standards of conduct in public life. More information about the Committee can be found on the Committee on Standards in Public Life GOV.UK page.

The Committee has eight members:

• a chair and four independent members are appointed by the Prime Minister, following open competition for a non-renewable, five year term of office
• three members are appointed on the recommendation of the leaders of the Conservative Party, the Labour Party and the Liberal Democrats

Both roles were advertised on the Centre for Public Appointments website, which sets out further details of the appointments.

Public Health England (PHE) has launched a new return on investment (ROI) tool to help local commissioners decide the best approach to preventing cardiovascular disease (CVD) within their populations.

CVD costs the NHS £7.4 billion each year and is one of the leading causes of death and disability in England, with deprived communities at greatest risk. Reducing the burden of CVD on local populations is an important step to helping people stay in work, boosting the local economy and lowering the future demand on health and social care settings.

The majority of CVD is preventable through identifying and managing risk earlier. The ROI tool shows the health and cost impacts of using different interventions to treat people at high risk of CVD, helping commissioners decide how their budget is best spent to improve local health outcomes. It also shows the effectiveness of different approaches to detecting and managing people with high risk conditions.

Professor Jamie Waterall, National Lead for Cardiovascular Disease Prevention at Public Health England, said:

We’re seeing the number of people with long-term conditions, such as diabetes, continue to rise which means prevention should be high on the agenda for the NHS. That is why this new tool is hugely useful in helping decision-makers make better choices about CVD prevention, based on the best evidence of what works. It will help commissioners plan effective CVD prevention strategies and make the most of their budgets to help more people live healthier, longer lives.

The ROI tool is the latest from PHE’s health economists underlining why investment in prevention is important to both the long term health of the population and the long term sustainability of the NHS. Assessments can be made at national, local authority, clinical commissioning group, or sustainability and transformation partnerships level.

Publication of the ROI tool coincides with a new Global Burden of Disease study highlighting the importance of national and local policies targeting prevention to tackle premature mortality. The study supports calls for renewed efforts to run systematic programmes to reduce chronic disease risk factors, including high blood pressure and high cholesterol.

The ROI tool lets users see predicted impacts of different interventions in terms of costs saved and the number of CVD events and premature deaths prevented. Analysis shows that optimising the use of statins and hypertensives could bring some of the most considerable cost-savings. The tool also highlights the importance of identifying risk earlier, with the earlier identification of diabetes predicted to provide the highest long-term benefits in terms of CVD events prevented and costs saved.

PHE commissioned the University of Sheffield to develop the tool, following an evidence review and in consultation with an expert steering group.

Dr. Matt Kearney, GP and National Clinical Director for Cardiovascular Disease Prevention at NHS England, said:

Heart attacks and strokes are life-changing events for sufferers and their families, and the NHS long term plan will set out a strategy for cardiovascular disease prevention and care. Thankfully these conditions are highly preventable and minimising their impact is not just good for patients but also benefits taxpayers who fund the NHS.

This return on investment tool will show health professionals in each part of the country how heart problems and strokes could be prevented, and how much health service resource could be freed up for reinvestment if we increase detection and treatment of high-risk conditions like atrial fibrillation, high blood pressure and high cholesterol.

Professor Brian Ferguson, Chief Economist at Public Health England, said:

This is a great addition to the suite of tools we’ve produced to support commissioners in local systems. It’s the first one that allows users to consider combinations of interventions, and so better reflects the reality of complex care needs. The results demonstrate that investing at scale in the most cost-effective preventative activities can deliver significant health benefits.

The tool and the accompanying report can be accessed online.

Commissioners can read further PHE advice on how to make the most of their budgets.

To find out more about the CVD ROI tool contact PHE’s Health Economics team.

Background

1. Interventions were chosen for inclusion in the tool if they were recommended by NICE for individuals without pre-existing CVD and if there was high quality and recent effectiveness evidence available. Selected detection interventions included NHS Health Checks, annual review in people with a pre-existing condition, cascade testing for FH and opportunistic detection. Selected management interventions included pharmacological interventions (antihypertensives, lipid modification therapy, anticoagulants and blood glucose lowering), lifestyle interventions (NHS diabetes prevention programme (DPP), diabetes structured education, weight management, smoking cessation, nutritional advice for CKD) and interventions that improve adherence to pharmacological interventions (blood pressure self-monitoring, insulin pump and medicines use review). A series of additional reviews were carried out to inform other intervention parameters including costs and duration of effect.
2. The tool was developed with input from a tool user group who provided information about local priorities for CVD and their requirements for a CVD prevention ROI tool. The tool design enables users to see the potential benefits of either improving detection and/or management of one or more high-risk conditions, or of improving the usage of one or more of the key interventions for people at risk of CVD. The tool is designed to include both the direct costs and benefits of implementing chosen scenarios and the indirect consequences, for example the increased cost of management that will occur as a response to increased diagnosis of high risk conditions.
3. The University of Sheffield developed the ROI tool based on a modification of an existing type 2 diabetes prevention model (The School for Public Health Research (SPHR) Diabetes Prevention Model), which has been previously used as the basis of a PHE tool to model the ROI of the NHS Diabetes Prevention Programme.
4. The tool includes demographic information about local populations, so that the outcomes are area-specific. Users can select localities of interest from the full range of CCGs, STPs and local authorities in England, or for the whole of England.
5. Primary prevention of CVD is not considered by the tool. However there is the functionality for users to assess the impact of additional interventions that are happening in their local area if they have information on effectiveness of the intervention.
6. Uncertainty analysis is not included in the tool, but it is important to note that there will be some uncertainty around estimates.
7. The tool lets users see the benefits of interventions around 6 CVD high risk conditions, identified by the NHS RightCare Optimal Pathway as currently underdiagnosed and insufficiently managed despite a range of available interventions, and therefore representing targets for improvement:

• high blood pressure
• atrial fibrillation (AF)
• high cholesterol/high CVD risk including familial hypercholesterolemia (FH)
• diabetes (type 2 and type 1)
• non-diabetic hyperglycaemia
• chronic kidney disease (CKD)